Data as of May 17
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 30.00, with a high estimate of 33.00 and a low estimate of 25.00. The median estimate represents a +34.35% increase from the last price of 22.33.
The current consensus among 4 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.